SenzaGen AB (SENZA.ST)

SEK 7.0

(0.0%)

Total Assets Summary of SenzaGen AB

SenzaGen AB's latest annual total assets in 2023 was 97.17 Million SEK , down -18.99% from previous year.
SenzaGen AB's latest quarterly total assets in 2024 Q2 was 118.5 Million SEK , up 28.88% from previous quarter.
SenzaGen AB reported annual total assets of 119.95 Million SEK in 2022, down -10.35% from previous year.
SenzaGen AB reported annual total assets of 133.8 Million SEK in 2021, up 19.95% from previous year.
SenzaGen AB reported quarterly total assets of 91.95 Million SEK for 2024 Q1, down -5.37% from previous quarter.
SenzaGen AB reported quarterly total assets of 97.17 Million SEK for 2023 Q3, down -4.55% from previous quarter.

Annual Total Assets Chart of SenzaGen AB (2023 - 2014)

Historical Annual Total Assets of SenzaGen AB (2023 - 2014)

Year	Total Assets	Total Assets Growth
2023	97.17 Million SEK	-18.99%
2022	119.95 Million SEK	-10.35%
2021	133.8 Million SEK	19.95%
2020	111.54 Million SEK	-21.97%
2019	142.96 Million SEK	58.02%
2018	90.46 Million SEK	-16.75%
2017	108.67 Million SEK	211.19%
2016	34.92 Million SEK	-23.0%
2015	45.35 Million SEK	897.82%
2014	4.54 Million SEK	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	118.5 Million SEK	28.88%
2024 Q1	91.95 Million SEK	-5.37%
2023 Q3	97.17 Million SEK	-4.55%
2023 Q1	101.81 Million SEK	-15.12%
2023 FY	97.17 Million SEK	-18.99%
2023 Q4	97.17 Million SEK	0.0%
2023 Q2	101.81 Million SEK	0.0%
2022 Q3	119.95 Million SEK	3.71%
2022 Q4	119.95 Million SEK	0.0%
2022 FY	119.95 Million SEK	-10.35%
2022 Q2	115.66 Million SEK	0.0%
2022 Q1	115.66 Million SEK	-13.56%
2021 Q1	97.84 Million SEK	-12.29%
2021 FY	133.8 Million SEK	19.95%
2021 Q4	133.8 Million SEK	0.0%
2021 Q3	133.8 Million SEK	36.75%
2021 Q2	97.84 Million SEK	0.0%
2020 Q3	111.54 Million SEK	-11.31%
2020 Q1	125.77 Million SEK	-12.02%
2020 Q2	125.77 Million SEK	0.0%
2020 FY	111.54 Million SEK	-21.97%
2020 Q4	111.54 Million SEK	0.0%
2019 Q4	142.96 Million SEK	0.0%
2019 FY	142.96 Million SEK	58.02%
2019 Q2	79.41 Million SEK	0.0%
2019 Q1	79.41 Million SEK	-12.22%
2019 Q3	142.96 Million SEK	80.02%
2018 Q2	103.44 Million SEK	0.0%
2018 Q3	90.46 Million SEK	-12.54%
2018 Q4	90.46 Million SEK	0.0%
2018 Q1	103.44 Million SEK	-4.81%
2018 FY	90.46 Million SEK	-16.75%
2017 Q3	108.67 Million SEK	209.67%
2017 Q4	108.67 Million SEK	0.0%
2017 Q1	35.09 Million SEK	0.49%
2017 Q2	35.09 Million SEK	0.0%
2017 FY	108.67 Million SEK	211.19%
2016 FY	34.92 Million SEK	-23.0%
2016 Q3	34.92 Million SEK	0.0%
2016 Q4	34.92 Million SEK	0.0%
2016 Q1	- SEK	0.0%
2015 FY	45.35 Million SEK	897.82%
2014 FY	4.54 Million SEK	0.0%

Peer Total Assets Comparison of SenzaGen AB

Name	Total Assets	Total Assets Difference
AroCell AB (publ)	174.89 Million SEK	44.437%
Devyser Diagnostics AB (publ)	510.1 Million SEK	80.95%
Immunovia AB (publ)	98.68 Million SEK	1.525%
Prostatype Genomics AB (publ)	49.22 Million SEK	-97.424%
Spermosens AB	26.1 Million SEK	-272.251%